DDHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.657600E-01
Normal-vs-Stage2
3.417000E-01
Normal-vs-Stage3
2.496600E-01
Normal-vs-Stage4
3.293600E-01
Stage1-vs-Stage2
7.803800E-01
Stage1-vs-Stage3
5.019600E-02
Stage1-vs-Stage4
6.276600E-01
Stage2-vs-Stage3
4.043200E-04
Stage2-vs-Stage4
8.182400E-01
Stage3-vs-Stage4
1.705990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.458400E-01
Normal-vs-AfricanAmerican
1.560830E-01
Normal-vs-Asian
2.745800E-01
Caucasian-vs-AfricanAmerican
8.636800E-01
Caucasian-vs-Asian
1.001980E-01
AfricanAmerican-vs-Asian
2.043000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.302200E-01
Normal-vs-Female
3.588800E-01
Male-vs-Female
2.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.123200E-01
Normal-vs-Age(41-60Yrs)
3.839200E-01
Normal-vs-Age(61-80Yrs)
3.269400E-01
Normal-vs-Age(81-100Yrs)
3.096000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.355200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.208600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.412800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.646400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.620030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.425400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.159800E-01
Normal-vs-Daily Drinker
3.403400E-01
Normal-vs-Weekly Drinker
3.323200E-01
Normal-vs-Occasional Drinker
3.172400E-01
Normal-vs-Social Drinker
4.024200E-01
Non Drinker-vs-Daily Drinker
6.644000E-01
Non Drinker-vs-Weekly Drinker
7.469200E-01
Non Drinker-vs-Occasional Drinker
9.660000E-01
Non Drinker-vs-Social Drinker
1.358820E-01
Daily Drinker-vs-Weekly Drinker
9.189000E-01
Daily Drinker-vs-Occasional Drinker
6.965000E-01
Daily Drinker-vs-Social Drinker
4.219800E-01
Weekly Drinker-vs-Occasional Drinker
7.552000E-01
Weekly Drinker-vs-Social Drinker
3.236600E-01
Occasional Drinker-vs-Social Drinker
1.704210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.040800E-01
Normal-vs-Grade 2
9.376200E-02
Normal-vs-Grade 3
1.121850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.292600E-01
Grade 1-vs-Grade 3
2.284000E-01
Grade 1-vs-Grade 4
3.040800E-01
Grade 2-vs-Grade 3
3.252000E-01
Grade 2-vs-Grade 4
9.376200E-02
Grade 3-vs-Grade 4
1.121850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.399600E-01
Normal-vs-NonDiabetic
3.264400E-01
Diabetic-vs-NonDiabetic
6.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.908400E-01
Normal-vs-NoPancreatitis
3.295800E-01
Pancreatitis-vs-NoPancreatitis
2.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.361400E-01
Normal-vs-N1
3.418600E-01
N0-vs-N1
8.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.187400E-01
Normal-vs-TP53-NonMutant
3.055400E-01
TP53-Mutant-vs-TP53-NonMutant
2.798700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
